Program Announced for GMPs Workshop
IQ has announced the program for its upcoming workshop on phase appropriate strategies for Drug Product Manufacturing Drug Substance and Drug Product Analytical Methods, Stability and Specifications. The meeting will feature a plenary Session followed by consecutive tracks covering each of the four key areas DP Manufacturing Analytical Methods for DS & DP Specifications for DS & DP Stability for DS & DP. Speakers will include scientists from the pharmaceutical industry and regulatory agencies.
Industry scientists and professionals involved in CMC development e.g. QA, CMC-regulatory, analytical and formulation development scientists, Supply Chain personnel CMC Regulatory scientists and professionals from FDA, EMA, Health Canada, and other agencies are all encouraged to attend. Due to venue constraints, participation is limited to the first 100 registrants.